CaMK
- Inhibitory Selectivity
- Solubility
| Catalog No. | Product Name | Solubility(25°C) | ||
|---|---|---|---|---|
| Water | DMSO | Alcohol | ||
| S7436 | NH125 | <1 mg/mL | 100 mg/mL | 100 mg/mL |
| S8274 | STO-609 | <1 mg/mL | 8 mg/mL | <1 mg/mL |
| S7423 | KN-93 Phosphate | 92 mg/mL | 100 mg/mL | <1 mg/mL |
| S7422 | KN-62 | <1 mg/mL | 100 mg/mL | <1 mg/mL |
| S8366 | CRT0066101 | 82 mg/mL | 25 mg/mL | 2 mg/mL |
| S7188 | CID755673 | <1 mg/mL | 43 mg/mL | <1 mg/mL |
| S7436 | NH125 | <1 mg/mL | 100 mg/mL | 100 mg/mL |
| S8274 | STO-609 | <1 mg/mL | 8 mg/mL | <1 mg/mL |
| S7423 | KN-93 Phosphate | 92 mg/mL | 100 mg/mL | <1 mg/mL |
| S7422 | KN-62 | <1 mg/mL | 100 mg/mL | <1 mg/mL |
| S8366 | CRT0066101 | 82 mg/mL | 25 mg/mL | 2 mg/mL |
| S7188 | CID755673 | <1 mg/mL | 43 mg/mL | <1 mg/mL |
Isoform-specific Inhibitors
- CaMK Inhibitors (12)
- New CaMK Products
| Catalog No. | Information | Product Use Citations | Product Validations |
|---|---|---|---|
| S7436 |
NH125NH125 is a selective eEF-2 kinase inhibitor with IC50 of 60 nM, >125-fold selectivity over PKC, PKA, and CaMKII, and also a potent histidine kinase inhibitor. |
NH125 sensitizes NPC cells to lapatinib. NPC cells were treated with lapatinib or DMSO for 48 h in the presence or absence of 0.25 μM NH125. Cell viability was assessed by the CCK-8 assay. Results are expressed as means±standard deviation. *, P<0.05;**, P<0.01 and ***, P<0.001.
|
|
| S8274 |
STO-609STO-609 is a specific inhibitor of the Ca2+/Calmodulin-dependent protein kinase kinase(CaM-KK) that inhibits the activities of recombinant CaM-KKα and CaM-KKβ isoforms, with Ki values of 80 and 15 ng/ml, respectively, and also inhibits their autophosphorylation activities. |
||
| S7423 |
KN-93 PhosphateKN-93 Phosphate is a potent and specific inhibitor of Ca2+/calmodulin-dependent protein kinase II (CaMKII) with Ki of 0.37 μM, no remarkable inhibitory effects on APK, PKC, MLCK or Ca2+-PDE activities. |
Paeoniflorin (PF) protects the heart against MI-induced injury in DM mice. Heart function was analyzed by measuring fractional shortening {FS = [LV end diastolic diameter (LVEDD)-LVend systolic diameter (LVESD)]×100/LVEDD} and LV ejection fraction [LVEF = (LVEDD2−LVESD2)/LVEDD2].
|
|
| S7422 |
KN-62KN-62 is a potent and specific inhibitor of Ca2+/calmodulin-dependent protein kinase II (CaMKII) with Ki of 0.9 μM; also a non-competitive antagonist of the purinergic receptor P2RX7 (IC50 = 15 nM). It is selective for CaMKII relative to PKA, PKC and MLCK, but inhibits CaMKI and CaMKIV equally well, The Ki value of KN-62 for CaMK V is 0.8 μM. |
(F) HEK239 cells were transfected with Flag-Cyclin D1 and Cyclin D1 siRNAs for 12 h, then cells were subjected to immunoblot detection. (G) DIV7 cortical neurons were treated with 10 μM KN62 or 15 μM Ntide and transfected with or without Cyclin D1 siRNAs for 24 h (Left panel), then apoptosis was determined. MW, molecular weight; kDa, kilodalton. All data in this figure represent the means ± SEM of three independent experiments. *P < 0.05.
|
|
| S8366 |
CRT0066101CRT0066101 is a small molecule PKD family specific inhibitor which specifically blocks PKD1/2 activity and does not suppress PKCα/PKCβ/PKCε activity in multiple. |
||
| S7188 |
CID755673CID755673 is a cell-active pan-PKD1/2/3 inhibitor with IC50 of 180 nM, 280nM, and 227 nM, respectively, about 200-fold selectivity over other CAMKs. |
||
| S7436 |
NH125NH125 is a selective eEF-2 kinase inhibitor with IC50 of 60 nM, >125-fold selectivity over PKC, PKA, and CaMKII, and also a potent histidine kinase inhibitor. |
NH125 sensitizes NPC cells to lapatinib. NPC cells were treated with lapatinib or DMSO for 48 h in the presence or absence of 0.25 μM NH125. Cell viability was assessed by the CCK-8 assay. Results are expressed as means±standard deviation. *, P<0.05;**, P<0.01 and ***, P<0.001.
|
|
| S8274 |
STO-609STO-609 is a specific inhibitor of the Ca2+/Calmodulin-dependent protein kinase kinase(CaM-KK) that inhibits the activities of recombinant CaM-KKα and CaM-KKβ isoforms, with Ki values of 80 and 15 ng/ml, respectively, and also inhibits their autophosphorylation activities. |
||
| S7423 |
KN-93 PhosphateKN-93 Phosphate is a potent and specific inhibitor of Ca2+/calmodulin-dependent protein kinase II (CaMKII) with Ki of 0.37 μM, no remarkable inhibitory effects on APK, PKC, MLCK or Ca2+-PDE activities. |
Paeoniflorin (PF) protects the heart against MI-induced injury in DM mice. Heart function was analyzed by measuring fractional shortening {FS = [LV end diastolic diameter (LVEDD)-LVend systolic diameter (LVESD)]×100/LVEDD} and LV ejection fraction [LVEF = (LVEDD2−LVESD2)/LVEDD2].
|
|
| S7422 |
KN-62KN-62 is a potent and specific inhibitor of Ca2+/calmodulin-dependent protein kinase II (CaMKII) with Ki of 0.9 μM; also a non-competitive antagonist of the purinergic receptor P2RX7 (IC50 = 15 nM). It is selective for CaMKII relative to PKA, PKC and MLCK, but inhibits CaMKI and CaMKIV equally well, The Ki value of KN-62 for CaMK V is 0.8 μM. |
(F) HEK239 cells were transfected with Flag-Cyclin D1 and Cyclin D1 siRNAs for 12 h, then cells were subjected to immunoblot detection. (G) DIV7 cortical neurons were treated with 10 μM KN62 or 15 μM Ntide and transfected with or without Cyclin D1 siRNAs for 24 h (Left panel), then apoptosis was determined. MW, molecular weight; kDa, kilodalton. All data in this figure represent the means ± SEM of three independent experiments. *P < 0.05.
|
|
| S8366 |
CRT0066101CRT0066101 is a small molecule PKD family specific inhibitor which specifically blocks PKD1/2 activity and does not suppress PKCα/PKCβ/PKCε activity in multiple. |
||
| S7188 |
CID755673CID755673 is a cell-active pan-PKD1/2/3 inhibitor with IC50 of 180 nM, 280nM, and 227 nM, respectively, about 200-fold selectivity over other CAMKs. |
